Skip to content

VKTX

Viking Therapeutics, Inc.

Stock

$29.94−0.57 (−1.87%)Close Oct 2, 2026

Revenue, 2025
$0

Revenue

Revenue by fiscal year

PeriodRevenueYoY
2025$0—
2024$0—
2023$0—
2022$0—
2021$0—
2020$0—
2019$0—
2018$0—
2017$0—
2016$0—
2015$0—
2014$0—